Morning Buzz: ImmunoCellular Therapeutics Ltd (IMUC), Merrimack Pharmaceuticals (MACK), Lipocine Inc (LPCN), Avanir Pharmaceuticals (AVNR)

Shares of ImmunoCellular Therapeutics Ltd (IMUC) are up almost 14% to $1.03 in pre-market trading Wednesday after the company announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest. Dr. […] View the full post at: Morning Buzz: ImmunoCellular Therapeutics Ltd (IMUC), Merrimack Pharmaceuticals (MACK), Lipocine Inc (LPCN), Avanir Pharmaceuticals (AVNR) No related posts.